Skandinaviska Enskilda Banken AB publ raised its stake in Colgate-Palmolive (NYSE:CL) by 0.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 144,647 shares of the company’s stock after purchasing an additional 1,300 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Colgate-Palmolive were worth $10,538,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Chip Partners Inc. lifted its holdings in shares of Colgate-Palmolive by 0.4% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after acquiring an additional 8 shares in the last quarter. AlphaMark Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after acquiring an additional 25 shares in the last quarter. Capital Investment Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 0.3% during the 2nd quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock valued at $617,000 after acquiring an additional 27 shares in the last quarter. Weatherstone Capital Management lifted its holdings in shares of Colgate-Palmolive by 0.7% during the 2nd quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock valued at $302,000 after acquiring an additional 28 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC lifted its holdings in shares of Colgate-Palmolive by 0.6% during the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock valued at $419,000 after acquiring an additional 34 shares in the last quarter. Institutional investors own 72.83% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) opened at $74.62 on Friday. The stock has a market cap of $65,524.20, a price-to-earnings ratio of 26.00, a P/E/G ratio of 3.15 and a beta of 0.80. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.73 EPS. analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s payout ratio is currently 61.78%.

In other news, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $73.28, for a total value of $549,600.00. Following the completion of the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jennifer Daniels sold 902 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the sale, the insider now directly owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. Insiders sold a total of 181,950 shares of company stock valued at $13,237,385 in the last three months. Insiders own 1.02% of the company’s stock.

CL has been the topic of several recent research reports. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a report on Monday, October 23rd. Deutsche Bank assumed coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Finally, Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Sunday, October 29th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $76.51.

ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive (CL) Shares Bought by Skandinaviska Enskilda Banken AB publ” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2018/01/14/colgate-palmolive-cl-shares-bought-by-skandinaviska-enskilda-banken-ab-publ.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.